- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02400580
IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy
Intravenous Acetaminophen Versus Saline in Postoperative Analgesia After Laparoscopic Hysterectomy: A Randomized, Double Blind, Placebo Controlled Trial
Panoramica dello studio
Descrizione dettagliata
Gynecologic surgery has been revolutionized by the incorporation of minimally invasive techniques. Procedures that once resulted in multiple day hospital admissions are now being performed in outpatient surgery centers. Common factors that contribute to delayed discharge are inadequate postoperative pain control and increased nausea and vomiting. A multi-modal pain management approach is considered optimal at controlling postsurgical pain, which includes combining different analgesics that act in varying mechanisms. By using medications that act synergistically, the overall analgesia requirement can oftentimes be decreased.
Opioids have been found to be highly effective in controlling postoperative pain; however, are associated with dose-dependent risks including nausea, vomiting, constipation, urinary retention, sedation, and respiratory depression. Subsequently, non-opioid options are frequently desired in an attempt to minimize narcotic intake. In the United States, intravenous acetaminophen was approved by the US Food and Drug Administration (FDA) in November 2010 for the management of mild to moderate pain and the reduction of fever. Since this time, multiple studies have analyzed the role of intravenous acetaminophen in both acute and postoperative pain; however, none have been specific to laparoscopic hysterectomy. The primary study published evaluating intravenous acetaminophen in laparoscopic hysterectomies also included multiple other laparoscopic procedures from a variety of specialties including general surgery, urology, and urogynecology. In addition, the intravenous acetaminophen was started on average 19 hours after the conclusion of the case once the patient controlled analgesic was discontinued.
Improved postsurgical pain control achieved with intravenous acetaminophen may potentially lead to same day discharge after major laparoscopic gynecologic procedures. Same day discharge after laparoscopic hysterectomy has been shown to be a safe option with proper patient counseling and multi-modal pain medications. In addition, same day discharge is also associated with decreased health care expenditures. With continued efforts to cut hospital costs, the pressure to discharge patients earlier continues to be high.
The investigators propose that intravenous acetaminophen will improve post-operative pain control and decrease narcotic requirements for patients undergoing laparoscopic hysterectomies. Furthermore, The investigators expect to find decreased postsurgical nausea and vomiting and potentially quicker discharge to home. This could have a large impact on the field of gynecologic surgery as major procedures that once required overnight admission may now succeed at same day discharge.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 4
Contatti e Sedi
Luoghi di studio
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Stati Uniti, 15213
- Magee Womens Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Women aged 18-75
- Ability to read and write in English (our post-operative pain log is only available in English)
- Planning a laparoscopic hysterectomy (includes total laparoscopic hysterectomy, laparoscopic supracervical hysterectomy, laparoscopically assisted vaginal hysterectomy, with or without salpingooophorectomy)
Exclusion Criteria:
- Answering yes to any of the following questions: "Do you have a history of liver disease, kidney disease, hepatitis C, history of liver failure, greater than 3 drinks per day or being have you ever been told by your doctor that they should not take acetaminophen"
- History of cardiac arrhythmia
- History of jaundice
- Acute abdominal inflammatory or infectious process at time of surgery
- Known malignancy at time of surgery
- Known pregnancy at time of surgery
- Plan to perform additional significant surgical procedure at the time of hysterectomy such as extensive excision of endometriosis on bowel or bladder or pelvic reconstructive procedure
- >6cm abdominal incision in order to remove the uterus at time of study-related hysterectomy
- Regular use of narcotic pain medication (defined as use on most days of the week at any point in the past 3 months)
- Allergy to acetaminophen
- Women who weigh less than 50 kilograms on the day of surgery.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Intravenous IV acetaminophen
The patients in the treatment arm will receive 1000mg of IV acetaminophen.
|
The patients in the treatment arm will receive 1000mg of IV acetaminophen.
Altri nomi:
|
Comparatore placebo: Normal Saline
The patients in the placebo arm will receive normal saline.
|
The patients in the placebo arm will receive normal saline.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Postoperative Pain
Lasso di tempo: 24 hours
|
The primary aim of this study is to compare overall post-surgical pain after hysterectomy as reported by the patients on a visual analog scale with a range of 0 to 10 where 0 is no pain at all and 10 is the worst pain that a person can imagine.
Less pain is considered preferable to more pain.
The theory is that patients who have intravenous acetaminophen will report less post-surgical pain.
|
24 hours
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Narcotic Medication Use
Lasso di tempo: 24 hours
|
The secondary outcome is comparison of narcotic pain medical requirements within the first 24 hours after surgery.
The hypothesis is that the intravenous acetaminophen group will require less narcotic medications than the placebo group.
Narcotic use in this study will be calculated by converting all narcotics (fentanyl, dilaudid etc) into standardized units of morphine using well validated conversion tables.
|
24 hours
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Having a Feeling of General Well-being at One Month
Lasso di tempo: 4 weeks
|
Quality of recovery will be evaluated through the use of the validated Quality of Recovery-40 questionnaire.
The hypothesis is that the intravenous acetaminophen group will experience an increased quality of recovery as compared to the placebo group.
|
4 weeks
|
Number of Participants Who Vomited Within 24 Hours of Operation
Lasso di tempo: 24 hours
|
A secondary aim of this study is to compare post-operative vomiting scores on post-operative day zero and one.
Vomiting is reported as either having vomited or not vomited.
The hypothesis is that the intravenous acetaminophen group will experience decreased vomiting compared with the placebo group.
|
24 hours
|
Readiness for Discharge
Lasso di tempo: 24 hours
|
Patient perception of satisfaction at time of discharge on post-operative day zero will be evaluated.
The hypothesis is that intravenous acetaminophen group will experience increased satisfaction for discharge than the placebo group.
|
24 hours
|
Nausea Before Surgery as Compared to After Surgery
Lasso di tempo: 24 hours
|
A secondary aim of this study is to compare post-operative nausea on post-operative day zero and one as reported by the patients on a visual analog scale with a range of 0 to 10 where 0 is no nausea at all and 10 is the worst nausea that a person can imagine.
Less nausea is considered preferable to more nausea.
The hypothesis is that the intravenous acetaminophen group will experience decreased nausea compared with the placebo group.
|
24 hours
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Noah Rindos, MD, Faculty
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PRO13110403
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Dolore
-
University of OklahomaThe Children's Hospital at OU Medical CenterCompletatoDolore addominale funzionale | Crisi falciforme | Pazienti seguiti dal Pain Team
Prove cliniche su IV acetaminophen
-
Healthgen Biotechnology Corp.Reclutamento
-
Eli Lilly and CompanyCompletato
-
C. R. BardCompletatoComplicazione dell'accesso vascolareStati Uniti
-
Eli Lilly and CompanyCompletatoMalattia di AlzheimerStati Uniti, Giappone
-
Prometheus Biosciences, Inc., a subsidiary of Merck...Altasciences Company Inc.Completato
-
Gmax Biopharm LLC.ReclutamentoIpertensione arteriosa polmonareStati Uniti, Cina
-
Eli Lilly and CompanyCompletato
-
BayerReclutamentoIpertensione polmonare dovuta a malattia del cuore sinistroGermania
-
Janssen-Cilag International NVCompletato
-
Asir John SamuelMaharishi Markendeswar University (Deemed to be University)ReclutamentoSindrome coronarica acutaIndia